Today We Are Closer To Measurably Improving Patient Lives

When I was 12 years old, I came home from school to learn that my father was diagnosed with a rare form of cancer. Later in life, I learned he had been misdiagnosed, and if it wasn’t for his gut feeling that the doctor was wrong, he wouldn’t be here with us today.

When it comes to their health, Americans don’t ask for second opinions enough. According to a poll from Harvard Medical School, 70% feel they don’t need to. If Americans aren’t compelled to get second opinions, we need to improve the initial care they receive. But how?

I dedicated the last decade to this charge. I got hands-on with clinical data and Memorial Sloan Kettering, built industry-first healthcare technology at DeepIntent, and strategized solutions to measurably improve patient lives.

Today, I have the answer.

It brings me great pleasure to announce the official launch of DeepIntent’s Patient Modeled Audiences. Our brilliant team of strategists, engineers, and data scientists have succeeded in developing a privacy-first, artificial intelligence (AI) solution that connects patients with the important and timely information they need to make better decisions about their health.

Patient Modeled Audiences combines emerging privacy technologies – like differential privacy – with artificial intelligence to build powerful advertising audiences based on social determinants. These precise, HIPAA-certified patient audiences have been rigorously tested in a closed beta that included a diverse cross-section of therapeutic categories and campaign goals. Our approach has been recognized by all 10 client participants as being a top performer – and in most cases, the best performer – among dozens of competing solutions.

In one case study, our audience placed 1st among 12 other data providers, yielding 25% higher Audience Quality and almost 60% higher efficiency on cost-per-treating-patient.

These results prove that the balance between privacy and performance is not zero-sum. With DeepIntent’s technology at the foundation, critical insights can be extracted from sensitive data while ensuring the utmost patient privacy. In turn, our clients will better identify patients in need, and share information that will drive better health outcomes. 

This endeavor represents the hard work of various teams within DeepIntent and across our strategic partners. Collectively, we committed more than a year to design, implement, and certify Patient Modeled Audiences. Today is a significant victory – not just for our company and our partners, but for patients. When we arm patients with the information they need to make informed decisions about their health, we will save lives.

Read more – Chris sat down with Business Insider to dive deeper on our privacy-safe AI, and using de-identified health data to improve ad efficiency and efficacy

More Insights

Driving NBRx and Improving AQ with Outcomes
Blog Post
Driving NBRx and Improving AQ: How DeepIntent Outcomes Delivers for Pharma Advertisers
There are more than 20,000 prescription drugs approved for marketing by the Food and Drug Administration (FDA). And yet, they all have one big thing...
Read More
Innovating With Intent 2023- The state of convergent TV
Blog Post
The State of Convergent TV: 3 Takeaways from Our Innovating with Intent Event
In its true form, convergence refers to the shift from analog to digital, something that’s been happening for many years. By 2022, Leichtman Research Group...
Read More
Switching from linear TV to CTV
Blog Post
Three Considerations for Healthcare Marketers Switching from Linear TV to CTV
For decades, traditional or linear TV has dominated the budgets of pharma advertisers. To meet industry recommendations developed decades ago, which call for audience sizes...
Read More
Back to Top